ANDA Amendments Should Trigger New Paragraph IV Certifications – Biovail

FDA's "ministerial role" in patent listing should include requiring ANDA applicants to re-certify to an innovator's patent each time a change is made to the CMC section of the ANDA, a Jan. 2 citizen petition submitted on behalf of Biovail says